Table 2.
Variables | Univariate Analysis | P | Multivariate Analysis | P | ||
---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | |||
Age(years) | ||||||
≥60/<60 | 0.860 | 0.563–1.231 | 0.329 | |||
Gender | ||||||
Male/Female | 1.183 | 0.618–2.265 | 0.610 | |||
Location | ||||||
Left/Right | 0.497 | 0.321–0.752 | 0.028 | 0.469 | 0.309–0.692 | 0.024 |
Pathology type | ||||||
Infiltrating/Ulcerative | 0.952 | 0.637–1.754 | 0.574 | |||
Differentiation | ||||||
Poorly/Well–moderatedly | 1.147 | 0.763–1.624 | 0.463 | |||
Depth of tumor invasion | ||||||
T2–3/T4 | 0.712 | 0.576–0.943 | 0.047 | 0.863 | 0.633–1.057 | 0.079 |
Lymph mode metastasis | ||||||
N1/N2 | 0.695 | 0.504–0.983 | 0.035 | 0.764 | 0.568–0.946 | 0.044 |
TNM stage | ||||||
III stage/IV stage | 0.574 | 0.368–0.889 | 0.037 | 0.565 | 0.341–0.863 | 0.019 |
CDK1 expression | ||||||
High expression/Low expression | 1.737 | 1.326–2.867 | 0.018 | 1.697 | 1.265–2.675 | 0.021 |
Abbreviations: HR, hazard ratio; CI, confidence interval.